KR101014246B1 - 페하 민감성 금속 나노 입자 및 이의 제조 방법. - Google Patents

페하 민감성 금속 나노 입자 및 이의 제조 방법. Download PDF

Info

Publication number
KR101014246B1
KR101014246B1 KR1020080064270A KR20080064270A KR101014246B1 KR 101014246 B1 KR101014246 B1 KR 101014246B1 KR 1020080064270 A KR1020080064270 A KR 1020080064270A KR 20080064270 A KR20080064270 A KR 20080064270A KR 101014246 B1 KR101014246 B1 KR 101014246B1
Authority
KR
South Korea
Prior art keywords
compound
sensitive
metal
metal nanoparticles
charge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020080064270A
Other languages
English (en)
Korean (ko)
Other versions
KR20100004220A (ko
Inventor
김성지
정상화
정효균
남주택
원나연
Original Assignee
포항공과대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020080064270A priority Critical patent/KR101014246B1/ko
Application filed by 포항공과대학교 산학협력단 filed Critical 포항공과대학교 산학협력단
Priority to EP09773753.0A priority patent/EP2308799B1/en
Priority to JP2011516156A priority patent/JP5577329B2/ja
Priority to US13/002,476 priority patent/US9616122B2/en
Priority to PCT/KR2009/003640 priority patent/WO2010002217A2/ko
Priority to CN200980125951.9A priority patent/CN102083741B/zh
Publication of KR20100004220A publication Critical patent/KR20100004220A/ko
Application granted granted Critical
Publication of KR101014246B1 publication Critical patent/KR101014246B1/ko
Priority to US15/438,698 priority patent/US20170226474A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0285—Nanoscale sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020080064270A 2008-07-03 2008-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법. Active KR101014246B1 (ko)

Priority Applications (7)

Application Number Priority Date Filing Date Title
KR1020080064270A KR101014246B1 (ko) 2008-07-03 2008-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법.
JP2011516156A JP5577329B2 (ja) 2008-07-03 2009-07-03 ｐＨ感受性金属ナノ粒子およびその製造方法
US13/002,476 US9616122B2 (en) 2008-07-03 2009-07-03 PH sensitive metal nanoparticle and preparation method
PCT/KR2009/003640 WO2010002217A2 (ko) 2008-07-03 2009-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법
EP09773753.0A EP2308799B1 (en) 2008-07-03 2009-07-03 Ph sensitive metal nanoparticle and preparation method
CN200980125951.9A CN102083741B (zh) 2008-07-03 2009-07-03 pH敏感性金属纳米粒子及其制造方法
US15/438,698 US20170226474A1 (en) 2008-07-03 2017-02-21 Ph sensitive metal and nanoparticle and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080064270A KR101014246B1 (ko) 2008-07-03 2008-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법.

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020100082619A Division KR101001906B1 (ko) 2010-08-25 2010-08-25 페하 민감성 화합물 및 그 제조 방법

Publications (2)

Publication Number Publication Date
KR20100004220A KR20100004220A (ko) 2010-01-13
KR101014246B1 true KR101014246B1 (ko) 2011-02-16

Family

ID=41466491

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080064270A Active KR101014246B1 (ko) 2008-07-03 2008-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법.

Country Status (6)

Country Link
US (2) US9616122B2 (https=)
EP (1) EP2308799B1 (https=)
JP (1) JP5577329B2 (https=)
KR (1) KR101014246B1 (https=)
CN (1) CN102083741B (https=)
WO (1) WO2010002217A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101196667B1 (ko) * 2010-04-15 2012-11-02 포항공과대학교 산학협력단 피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
KR101276693B1 (ko) * 2010-10-29 2013-06-19 포항공과대학교 산학협력단 양쪽성 이온을 가진 나노입자 표면 개질용 표면 분자체의 합성과 그 응용
KR101368179B1 (ko) * 2010-11-12 2014-03-03 포항공과대학교 산학협력단 강한 전하를 가지는 나노입자 표면 분자체와 이를 이용한 생접합 및 층상 자기조립 방법
WO2012174287A1 (en) * 2011-06-15 2012-12-20 The Board Of Regents Of The University Of Texas System Luminescent nanoparticle compositions
US20130189367A1 (en) * 2011-07-29 2013-07-25 University Of Washington Through Its Center For Commercialization Nanovectors for targeted gene silencing and cytotoxic effect in cancer cells
CN102989016A (zh) * 2012-11-05 2013-03-27 浙江大学 一种具有pH敏感性的纳米微粒材料及其制备方法
KR20140092430A (ko) * 2012-12-26 2014-07-24 삼성전자주식회사 나노입자 조립체, 이의 제조방법 및 이를 포함하는 활성물질 전달 복합체
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
US9874554B1 (en) 2014-07-16 2018-01-23 Verily Life Sciences Llc Aptamer-based in vivo diagnostic system
CN104667301B (zh) * 2015-02-12 2017-08-22 东北师范大学 一种单分散核壳结构AuNCs‑A@CaP纳米粒子的制备方法及其应用
JP2019512486A (ja) * 2016-03-08 2019-05-16 チルドレンズ ナショナル メディカル センターＣｈｉｌｄｒｅｎ’Ｓ Ｎａｔｉｏｎａｌ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ 官能化されたプルシアンブルーナノ粒子、組合せプルシアンブルーナノ粒子ベースのナノ免疫療法およびその適用
CN107941778A (zh) * 2017-10-11 2018-04-20 南方医科大学南方医院 一种用于检测体液pH的传感器及其制备和应用方法
CN111514308B (zh) * 2020-03-10 2023-02-17 西南民族大学 pH诱导电荷翻转型抗菌金纳米棒及其制备方法和应用
CN113899732B (zh) * 2021-09-30 2023-09-22 航天科工(长沙)新材料研究院有限公司 pH值敏感型配体修饰纳米金及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340527C (en) * 1988-05-31 1999-05-04 Lidia Vallarino Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
DE60115667T2 (de) 2000-09-05 2006-08-24 Centelion Säureempfindliche verbindungen, deren herstellung und verwendungen
GB0321937D0 (en) 2003-09-19 2003-10-22 Univ Liverpool Nanoparticle conjugates and method of production thereof
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
KR100645597B1 (ko) 2005-03-24 2006-11-14 이지로보틱스 주식회사 로봇 리모컨 서비스 방법 및 장치
KR100713745B1 (ko) * 2006-02-27 2007-05-07 연세대학교 산학협력단 상전이 리간드로 코팅된 수용성 자성 또는 금속 산화물나노입자 및 이의 제조방법
KR20080008668A (ko) 2006-07-20 2008-01-24 재단법인서울대학교산학협력재단 자성체 나노입자를 이용하여 단백질을 선택적으로 결합,분리 또는 정제하는 방법
KR100802080B1 (ko) 2007-03-28 2008-02-11 성균관대학교산학협력단 ｐＨ 민감성 블록 공중합체 및 이를 이용한 고분자 마이셀

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gupta, V. K. et al. Journal of Colloid and Interface Science, 2007, 316, 977-983.
KRISHNAN, S. et al. Nano Letters, 2008, Vol. 8, No. 5, 1492-1500 (2008.04.16).

Also Published As

Publication number Publication date
KR20100004220A (ko) 2010-01-13
EP2308799B1 (en) 2017-11-08
JP2011526883A (ja) 2011-10-20
CN102083741B (zh) 2015-11-25
US20170226474A1 (en) 2017-08-10
WO2010002217A2 (ko) 2010-01-07
US9616122B2 (en) 2017-04-11
JP5577329B2 (ja) 2014-08-20
WO2010002217A3 (ko) 2010-06-24
EP2308799A4 (en) 2014-12-17
CN102083741A (zh) 2011-06-01
US20110269170A1 (en) 2011-11-03
EP2308799A2 (en) 2011-04-13

Similar Documents

Publication Publication Date Title
KR101014246B1 (ko) 페하 민감성 금속 나노 입자 및 이의 제조 방법.
Kumar et al. A review on plant derived carbon quantum dots for bio-imaging
Singh et al. Carbon quantum dots: Synthesis, characterization and biomedical applications
Li et al. Highly N, P-doped carbon dots: rational design, photoluminescence and cellular imaging
Xue et al. A 980 nm laser-activated upconverted persistent probe for NIR-to-NIR rechargeable in vivo bioimaging
Barhoum et al. A review on carbon dots as innovative materials for advancing biomedical applications: synthesis, opportunities, and challenges
Chen et al. Controllable synthesis of NaYF4: Yb, Er upconversion nanophosphors and their application to in vivo imaging of Caenorhabditis elegans
Zeng et al. Dual-modal fluorescent/magnetic bioprobes based on small sized upconversion nanoparticles of amine-functionalized BaGdF 5: Yb/Er
Qian et al. Gold decorated NaYF4: Yb, Er/NaYF4/silica (core/shell/shell) upconversion nanoparticles for photothermal destruction of BE (2)-C neuroblastoma cells
CN105969330B (zh) 一种石墨烯纳米材料的制备方法
US9333271B2 (en) Coated up-conversion nanoparticles
Dutta et al. Bimetallic silver nanoparticle–gold nanocluster embedded composite nanoparticles for cancer theranostics
US20120190975A1 (en) Nanoparticles for use in tumor diagnosis and therapy
Angamuthu et al. Quick microwave assisted synthesis and in vitro imaging application of oxygen doped fluorescent carbon dots
Li et al. Fabrication of NaYF4: Yb, Er nanoprobes for cell imaging directly by using the method of hydrion rivalry aided by ultrasonic
Xu et al. Silane modified upconversion nanoparticles with multifunctions: imaging, therapy and hypoxia detection
CN104491882A (zh) 同时用作光声成像造影剂和光热治疗剂的纳米硫化铜诊疗剂及其制备方法
Du et al. Decoration of upconversion nanocrystals with metal sulfide quantum dots by a universal in situ controlled growth strategy
CN108175859B (zh) 一种多模磁光热诊疗一体化纳米探针及其制备方法和应用
Singh et al. Influence of surface states on the optical and cellular property of thermally stable red emissive graphitic carbon dots
Jiang et al. A Au nanoflower@ SiO 2@ CdTe/CdS/ZnS quantum dot multi-functional nanoprobe for photothermal treatment and cellular imaging
CN116041247B (zh) 一种光热试剂、光热试剂纳米颗粒及其制备方法
KR101001906B1 (ko) 페하 민감성 화합물 및 그 제조 방법
Yin et al. Study of gold nanostar@ SiO2@ CdTeS quantum dots@ SiO2 with enhanced-fluorescence and photothermal therapy multifunctional cell nanoprobe
Fan et al. Synergistic effects of Au nanoparticles in SiO2@ Au@ Polyaniline system for improved photothermal performance

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20080703

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100531

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0107 Divisional application

Comment text: Divisional Application of Patent

Patent event date: 20100825

Patent event code: PA01071R01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20101230

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20110207

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20110207

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20131231

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20131231

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20151224

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20151224

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20170123

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20170123

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20180125

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20180125

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20190102

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20190102

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20200102

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20200102

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20201229

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20211227

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20240119

Start annual number: 14

End annual number: 14